Ignite Creation Date:
2024-05-06 @ 1:44 PM
Last Modification Date:
2024-10-26 @ 1:19 PM
Study NCT ID:
NCT04107727
Status:
UNKNOWN
Last Update Posted:
2022-01-21
First Post:
2019-09-25
Brief Title:
Trial to Compare Efficacy and Safety of ChemotherapyQuizartinib vs ChemotherapyPlacebo in Adults FMS-like Tyrosine Kinase 3 FLT3 Wild-type Acute Myeloid Leukemia AML
Sponsor:
PETHEMA Foundation
Organization:
PETHEMA Foundation
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-09-05
Start Date Type:
ACTUAL
Primary Completion Date:
2024-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-09
Completion Date Type:
ESTIMATED
First Submit Date:
2019-09-25
First Submit QC Date:
September 26 2019
Study First Post Date:
2019-09-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-20
Last Update Post Date:
2022-01-21
Last Update Post Date Type:
ACTUAL